Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor)

MLA

Pires de Camargo, Veridiana, et al. “Clinical Outcomes of Systemic Therapy for Patients with Deep Fibromatosis (Desmoid Tumor).” Cancer, vol. 116, no. 9, May 2010, p. 2258. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.226229655&authtype=sso&custid=ns315887.

APA

Pires de Camargo, V., Keohan, M. L., D’Adamo, D. R., Antonescu, C. R., Brennan, M. F., Singer, S., Ahn, L. S., & Maki, R. G. (2010, May 1). Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). Cancer, 116(9), 2258.

Chicago

Pires de Camargo, Veridiana, Mary L. Keohan, David R. D’Adamo, Cristina R. Antonescu, Murray F. Brennan, Samuel Singer, Linda S. Ahn, and Robert G. Maki. 2010. “Clinical Outcomes of Systemic Therapy for Patients with Deep Fibromatosis (Desmoid Tumor).” Cancer, May 1. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.226229655&authtype=sso&custid=ns315887.